| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $1,100,000 ) |
| | 2023 | 2023 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 4 | CDC | 8/31/2023 | $50,000 |
| | 2023 | 2023 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 4 | CDC | 8/31/2023 | $50,000 |
| | 2023 | 2023 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 4 | CDC | 8/31/2023 | $350,000 |
| | 2023 | 2023 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 4 | CDC | 8/31/2023 | $650,000 |
| | 2023 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 3 | CDC | 11/29/2022 | $0 |
| | 2023 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 4 | CDC | 8/31/2023 | $0 |
| | 2023 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 3 | CDC | 11/29/2022 | -$193,311 |
| | 2023 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 4 | CDC | 8/31/2023 | $0 |
| | 2023 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 3 | CDC | 11/29/2022 | $193,311 |
| | 2023 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 4 | CDC | 8/31/2023 | $0 |
| | 2023 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 4 | CDC | 8/31/2023 | $0 |
| | 2023 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 3 | CDC | 11/29/2022 | $0 |
| | 2023 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 3 | CDC | 11/29/2022 | $0 |
| | 2023 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 4 | CDC | 8/31/2023 | $0 |
| | 2023 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 4 | CDC | 8/31/2023 | $0 |
| | 2023 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 3 | CDC | 11/29/2022 | $0 |
| | 2023 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 4 | CDC | 8/31/2023 | $0 |
| | 2023 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 3 | CDC | 11/29/2022 | $0 |
| | 2023 | 2021 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 4 | CDC | 8/31/2023 | $0 |
| | 2023 | 2021 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 3 | CDC | 11/29/2022 | $0 |
| | 2023 | 2021 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 4 | CDC | 8/31/2023 | $0 |
| | 2023 | 2021 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 3 | CDC | 11/29/2022 | $0 |
| | 2023 | 2021 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 4 | CDC | 8/31/2023 | $0 |
| | 2023 | 2021 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 3 | CDC | 11/29/2022 | $0 |
| | 2023 | 2021 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 4 | CDC | 8/31/2023 | $0 |
| | 2023 | 2021 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 3 | CDC | 11/29/2022 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $3,769,548 ) (Continued on the next page) |
| | 2022 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 3 | CDC | 8/19/2022 | $2,000,000 |
| | 2022 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 3 | CDC | 8/19/2022 | $250,000 |
| | 2022 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 3 | CDC | 8/19/2022 | $416,237 |
| | 2022 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 3 | CDC | 8/19/2022 | $660,000 |
| | 2022 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 3 | CDC | 8/19/2022 | $193,311 |
| | 2022 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 3 | CDC | 8/19/2022 | $250,000 |
| | 2022 | 2021 | Infectious Diseases Society Of America | 4040 Wilson Blvd # 300 | Arlington | VA | 22203-4434 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 03 | 2 | CDC | 11/5/2021 | $0 |
| | 2022 | 2021 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 3 | CDC | 8/19/2022 | $0 |
| | 2022 | 2021 | Infectious Diseases Society Of America | 4040 Wilson Blvd # 300 | Arlington | VA | 22203-4434 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 03 | 2 | CDC | 11/5/2021 | $0 |
| | 2022 | 2021 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 3 | CDC | 8/19/2022 | $0 |
| | 2022 | 2021 | Infectious Diseases Society Of America | 4040 Wilson Blvd # 300 | Arlington | VA | 22203-4434 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 03 | 2 | CDC | 11/5/2021 | $0 |
| | 2022 | 2021 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 04 | 2 | CDC | 6/7/2022 | $0 |
| | 2022 | 2021 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 04 | 2 | CDC | 6/7/2022 | $0 |
| | 2022 | 2021 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 04 | 2 | CDC | 6/7/2022 | $0 |
| | 2022 | 2021 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 04 | 2 | CDC | 6/7/2022 | $0 |
| | 2022 | 2021 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 05 | 2 | CDC | 9/6/2022 | $0 |
| | 2022 | 2021 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 05 | 2 | CDC | 9/6/2022 | $0 |
| | 2022 | 2021 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 05 | 2 | CDC | 9/6/2022 | $0 |
| | 2022 | 2021 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 3 | CDC | 8/19/2022 | $0 |
| | 2022 | 2021 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 05 | 2 | CDC | 9/6/2022 | $0 |
| | 2022 | 2021 | Infectious Diseases Society Of America | 4040 Wilson Blvd # 300 | Arlington | VA | 22203-4434 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 03 | 2 | CDC | 11/5/2021 | $0 |
| | 2022 | 2021 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 3 | CDC | 8/19/2022 | $0 |
|
